FDA Rejects Apricus Biosciences' Erectile Dysfunction Cream Vitaros Post author:Sam Post published:February 15, 2018 Post category:BioPharma The CRL indicates that the FDA cannot approve the NDA for Vitaros in its present form. Source: BioSpace You Might Also Like Unknown Group of Traders Earned $4.9M Before Sanofi-Bioverativ Deal January 29, 2018 Cambridge's 30-Person to Dissolve This Week June 4, 2017 Dicerna Could Pocket $201M in NASH R&D Deal With Boehringer Ingelheim November 1, 2017
